Life Changing Drug for Prevention of Migraine Now Approved

Migraine is the 3rd most prevalent illness in the world and almost 1 in every 4 house in the US will have one member at least suffering from it. 12% of the population which includes children suffers from this nerve-wracking condition among which 18% are women. Migraine is common between the ages of 18 and 44 and can also run in families where 90% of sufferers have a family history of migraine. Fortunately for several migraine sufferers in the US, there is good news.

Advertisement

1New migraine preventive treatment now available

Now those suffering from migraine where medication doesn’t work, there is a new option of treatment as announced by the NHS (food and drug administration) on March 12. The pill is called fremanezumab, that’s a long name but it is among three different medications that don’t just treat migraine symptoms but also prevent migraines from occurring.

Drug for Prevention of Migraine Now Approved

Image Source: medicinenet.com

Advertisement

2Approved earlier by the FDA in 2018

In 2018, the FDA in USA had just only approved three medications erenumab (Aimovig), fremanezumab (Ajovy), and galcanezumab (Emgality). These were the first three drugs that were specially designed to prevent migraine and reduce their intensity and duration. The news was huge especially since other migraine medication was also created to treat other conditions like seizures, depressions, high blood pressure and irregular heartbeat. The side effects were not ideal and this made many skip these medicines.

Image Source: twimg.com

Advertisement

3The new drug will soon be available in the UK

Now the National Institute for Health and Care Excellence (NICE) has also published its final draft guidance for fremanezumab which will pave the way for thousands of people to receive the drug in England’s NHS as well. The drug is required to be taken only once a month as an injection and will first be given to adults suffering from chronic migraines and on whom other treatments haven’t had much success.

Migraine research is promoted by the Migraine trust that also helps migraine sufferers. It defines chronic migraine as a condition in which a person will experience 15 or more headache days in a month out of which 8 or more days will include having a migraine.

Advertisement

Image Source: www.intelligentliving.co

Advertisement

You may also like...